Top Section/Ad
Top Section/Ad
Most recent
Italian shipbuilder is expanding capacity on strong defence demand
Deal priced at 1% premium to Monday's close
Booming metal prices could bring more equity deals
More articles/Ad
More articles/Ad
More articles
-
Bionor Pharma, the Norwegian biotech firm focused on developing a cure for HIV, will raise Nkr104m ($12.6m) after it simultaneously priced its private placement and announced a fully underwritten rights issue on Thursday. -
A handful of small deals enlivened a typical August week for ECM activity in London, with the Alternative Investment Market at the centre of the action.
-
China Resources Beer (Holdings) Co has wrapped up a multiple times oversubscribed rights issue, netting HK$9.5bn ($1.2bn), according to a filing with the Hong Kong Stock Exchange.
-
August has been a volatile month in recent years, with the Chinese devaluation last summer and a flare-up in Greece's debt crisis. Yet so far indices have remained stable this time. Stability could also be torpor if primary activity is anything to go by. Just a handful of small European deals in progress show a market in the full grip of the summer slowdown.
-
TwentyFour Income Fund, a listed fund from TwentyFour Asset Management, the UK asset manager specialising in fixed income, has launched its second capital increase of the summer, to satisfy additional demand and finance the purchase of new securities backed by Dutch consumer loans and British mortgages.
-
Trader Media East, the largest classified advertising firm in central and eastern Europe, has said it will carry out a seven-for-one share offering worth $88m net of expenses.
